These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34696348)

  • 1. Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H.
    Hazini A; Dieringer B; Klingel K; Pryshliak M; Geisler A; Kobelt D; Daberkow O; Kurreck J; Linthout SV; Fechner H
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan Sulfate Binding Coxsackievirus B3 Strain PD: A Novel Avirulent Oncolytic Agent Against Human Colorectal Carcinoma.
    Hazini A; Pryshliak M; Brückner V; Klingel K; Sauter M; Pinkert S; Kurreck J; Fechner H
    Hum Gene Ther; 2018 Nov; 29(11):1301-1314. PubMed ID: 29739251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines.
    Lin Y; Wang W; Wan J; Yang Y; Fu W; Pan D; Cai L; Cheng T; Huang X; Wang Y
    Virol J; 2018 Apr; 15(1):65. PubMed ID: 29631630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-375- and miR-1-Regulated Coxsackievirus B3 Has No Pancreas and Heart Toxicity But Strong Antitumor Efficiency in Colorectal Carcinomas.
    Hazini A; Dieringer B; Pryshliak M; Knoch KP; Heimann L; Tolksdorf B; Pappritz K; El-Shafeey M; Solimena M; Beling A; Kurreck J; Klingel K; Fechner H
    Hum Gene Ther; 2021 Feb; 32(3-4):216-230. PubMed ID: 33481658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.
    Pinkert S; Pryshliak M; Pappritz K; Knoch K; Hazini A; Dieringer B; Schaar K; Dong F; Hinze L; Lin J; Lassner D; Klopfleisch R; Solimena M; Tschöpe C; Kaya Z; El-Shafeey M; Beling A; Kurreck J; Van Linthout S; Klingel K; Fechner H
    Cardiovasc Res; 2020 Aug; 116(10):1756-1766. PubMed ID: 31598635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fast Track Adaptation of Oncolytic Coxsackie B3 Virus to Resistant Colorectal Cancer Cells - a Method to Personalize Virotherapy.
    Elsner L; Heimann L; Geisler A; Dieringer B; Knoch KP; Hinze L; Klingel K; Solimena M; Kurreck J; Fechner H
    Biol Proced Online; 2024 Apr; 26(1):11. PubMed ID: 38664647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coxsackievirus B3-Its Potential as an Oncolytic Virus.
    Geisler A; Hazini A; Heimann L; Kurreck J; Fechner H
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33919076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of FOLFOXIRI Drugs with Oncolytic Coxsackie B3 Virus PD-H Synergistically Induces Oncolysis in the Refractory Colorectal Cancer Cell Line Colo320.
    Girod M; Geisler A; Hinze L; Elsner L; Dieringer B; Beling A; Kurreck J; Fechner H
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a microRNA-Regulated Oncolytic Coxsackievirus B3.
    Dieringer B; Elsner L; Hazini A; Kurreck J; Fechner H
    Methods Mol Biol; 2022; 2521():259-282. PubMed ID: 35733003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic activity of a coxsackievirus B3 strain in patient-derived cervical squamous cell carcinoma organoids and synergistic effect with paclitaxel.
    Lin Y; Liu N; Yang C; Tan H; Fang C; Yu K; Zhao H; Xia N; Wang W; Huang X; Cheng T
    Virol J; 2024 Oct; 21(1):245. PubMed ID: 39369233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effects of Mesenchymal Stem Cells Loaded with Oncolytic
    Karbalaee R; Mehdizadeh S; Ghaleh HEG; Izadi M; Kondori BJ; Dorostkar R; Hosseini SM
    Curr Cancer Drug Targets; 2024; 24(9):967-974. PubMed ID: 38310465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma.
    Miyamoto S; Inoue H; Nakamura T; Yamada M; Sakamoto C; Urata Y; Okazaki T; Marumoto T; Takahashi A; Takayama K; Nakanishi Y; Shimizu H; Tani K
    Cancer Res; 2012 May; 72(10):2609-21. PubMed ID: 22461509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Combination Therapy for Human Oxaliplatin-resistant Colorectal Cancer Using Oxaliplatin and Coxsackievirus A11.
    Wang B; Ogata H; Takishima Y; Miyamoto S; Inoue H; Kuroda M; Yamada K; Hijikata Y; Murahashi M; Shimizu H; Okazaki T; Nakanishi Y; Tani K
    Anticancer Res; 2018 Nov; 38(11):6121-6126. PubMed ID: 30396927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-375-mediated suppression of engineered coxsackievirus B3 in pancreatic cells.
    Pryshliak M; Hazini A; Knoch K; Dieringer B; Tolksdorf B; Solimena M; Kurreck J; Pinkert S; Fechner H
    FEBS Lett; 2020 Feb; 594(4):763-775. PubMed ID: 31643074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Oncolysis of Enterovirus 71 in Antitumor Therapy of Colorectal Cancer.
    Ruan Z; Chi J; Kong Y; Li C; Ruan X; Zhou X; Chen Y; Li Y; Luo Z
    Adv Biol (Weinh); 2023 Jul; 7(7):e2200336. PubMed ID: 37132155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-Tumor Effect of a Novel Oncolytic Virus Based on Chimpanzee Adenovirus Type 6].
    Wang Q; Wang YH; Li Y; Xing M; Zhou DM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):71-76. PubMed ID: 35048603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new miRNA-Modified coxsackievirus B3 inhibits triple negative breast cancer growth with improved safety profile in immunocompetent mice.
    Bahreyni A; Liu H; Mohamud Y; Xue YC; Zhang J; Luo H
    Cancer Lett; 2022 Nov; 548():215849. PubMed ID: 35995138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68.
    Ehrig K; Kilinc MO; Chen NG; Stritzker J; Buckel L; Zhang Q; Szalay AA
    J Transl Med; 2013 Mar; 11():79. PubMed ID: 23531320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
    Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved replication efficiency of echovirus 5 after transfection of colon cancer cells using an authentic 5' RNA genome end methodology.
    Israelsson S; Sävneby A; Ekström JO; Jonsson N; Edman K; Lindberg AM
    Invest New Drugs; 2014 Dec; 32(6):1063-70. PubMed ID: 25052234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.